The recognition and management of oncologic emergencies are becoming increasingly relevant in the intensive care unit, particularly in the era of novel biologic therapies. Early recognition and multidisciplinary collaboration are essential to improving patient outcomes. This article discusses aspects of diagnosis and management for important malignancy-associated emergencies.
Keywords: Cytokine release syndrome; Hyperleukocytosis and leukostasis; Immune-related adverse events; Malignant pericardial effusion; Metastatic spinal cord compression; Superior vena cava syndrome; Syndrome of inappropriate antidiuretic hormone; Tumor lysis syndrome.
Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.